Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Epstein-Barr virus activates F-box protein FBXO2 to limit viral infectivity by targeting glycoprotein B for degradation.

Zhang HJ, Tian J, Qi XK, Xiang T, He GP, Zhang H, Yu X, Zhang X, Zhao B, Feng QS, Chen MY, Zeng MS, Zeng YX, Feng L.

PLoS Pathog. 2018 Jul 27;14(7):e1007208. doi: 10.1371/journal.ppat.1007208. eCollection 2018 Jul.

2.

The Immunomodulatory Capacity of an Epstein-Barr Virus Abortive Lytic Cycle: Potential Contribution to Viral Tumorigenesis.

Morales-Sánchez A, Fuentes-Panana EM.

Cancers (Basel). 2018 Mar 30;10(4). pii: E98. doi: 10.3390/cancers10040098. Review.

3.

Hyperjaponol H, A New Bioactive Filicinic Acid-Based Meroterpenoid from Hypericum japonicum Thunb. ex Murray.

Wu R, Le Z, Wang Z, Tian S, Xue Y, Chen Y, Hu L, Zhang Y.

Molecules. 2018 Mar 18;23(3). pii: E683. doi: 10.3390/molecules23030683.

4.

New Insights from Elucidating the Role of LMP1 in Nasopharyngeal Carcinoma.

Shair KHY, Reddy A, Cooper VS.

Cancers (Basel). 2018 Mar 21;10(4). pii: E86. doi: 10.3390/cancers10040086. Review.

5.

EBV transformation induces overexpression of hMSH2/3/6 on B lymphocytes and enhances γδT-cell-mediated cytotoxicity via TCR and NKG2D.

Dai YM, Liu HY, Liu YF, Zhang Y, He W.

Immunology. 2018 Mar 7. doi: 10.1111/imm.12920. [Epub ahead of print]

PMID:
29512904
6.

Epstein-Barr virus infection and nasopharyngeal carcinoma.

Tsao SW, Tsang CM, Lo KW.

Philos Trans R Soc Lond B Biol Sci. 2017 Oct 19;372(1732). pii: 20160270. doi: 10.1098/rstb.2016.0270. Review.

7.

A comparative review of viral entry and attachment during large and giant dsDNA virus infections.

Sobhy H.

Arch Virol. 2017 Dec;162(12):3567-3585. doi: 10.1007/s00705-017-3497-8. Epub 2017 Sep 2. Review.

8.

Epstein-Barr virus (EBV)-associated epithelial and non-epithelial lesions of the oral cavity.

Kikuchi K, Inoue H, Miyazaki Y, Ide F, Kojima M, Kusama K.

Jpn Dent Sci Rev. 2017 Aug;53(3):95-109. doi: 10.1016/j.jdsr.2017.01.002. Epub 2017 Mar 15. Review.

9.

Novel Epstein-Barr virus-like particles incorporating gH/gL-EBNA1 or gB-LMP2 induce high neutralizing antibody titers and EBV-specific T-cell responses in immunized mice.

Perez EM, Foley J, Tison T, Silva R, Ogembo JG.

Oncotarget. 2017 Mar 21;8(12):19255-19273. doi: 10.18632/oncotarget.13770.

10.

CFTR is a potential marker for nasopharyngeal carcinoma prognosis and metastasis.

Tu Z, Chen Q, Zhang JT, Jiang X, Xia Y, Chan HC.

Oncotarget. 2016 Nov 22;7(47):76955-76965. doi: 10.18632/oncotarget.12762.

11.

Cell Surface THY-1 Contributes to Human Cytomegalovirus Entry via a Macropinocytosis-Like Process.

Li Q, Fischer E, Cohen JI.

J Virol. 2016 Oct 14;90(21):9766-9781. Print 2016 Nov 1.

12.

Neuropilin-1 is a receptor for extracellular miRNA and AGO2/miRNA complexes and mediates the internalization of miRNAs that modulate cell function.

Prud'homme GJ, Glinka Y, Lichner Z, Yousef GM.

Oncotarget. 2016 Oct 18;7(42):68057-68071. doi: 10.18632/oncotarget.10929.

13.

BZLF1 Attenuates Transmission of Inflammatory Paracrine Senescence in Epstein-Barr Virus-Infected Cells by Downregulating Tumor Necrosis Factor Alpha.

Long X, Li Y, Yang M, Huang L, Gong W, Kuang E.

J Virol. 2016 Aug 12;90(17):7880-93. doi: 10.1128/JVI.00999-16. Print 2016 Sep 1.

14.

Virion Glycoprotein-Mediated Immune Evasion by Human Cytomegalovirus: a Sticky Virus Makes a Slick Getaway.

Gardner TJ, Tortorella D.

Microbiol Mol Biol Rev. 2016 Jun 15;80(3):663-77. doi: 10.1128/MMBR.00018-16. Print 2016 Sep. Review.

15.

New strategies against drug resistance to herpes simplex virus.

Jiang YC, Feng H, Lin YC, Guo XR.

Int J Oral Sci. 2016 Mar 30;8(1):1-6. doi: 10.1038/ijos.2016.3. Review.

16.

Spironolactone blocks Epstein-Barr virus production by inhibiting EBV SM protein function.

Verma D, Thompson J, Swaminathan S.

Proc Natl Acad Sci U S A. 2016 Mar 29;113(13):3609-14. doi: 10.1073/pnas.1523686113. Epub 2016 Mar 14.

17.

Extracellular Vesicles Exploit Viral Entry Routes for Cargo Delivery.

van Dongen HM, Masoumi N, Witwer KW, Pegtel DM.

Microbiol Mol Biol Rev. 2016 Mar 2;80(2):369-86. doi: 10.1128/MMBR.00063-15. Print 2016 Jun. Review.

18.

ISG15 predicts poor prognosis and promotes cancer stem cell phenotype in nasopharyngeal carcinoma.

Chen RH, Du Y, Han P, Wang HB, Liang FY, Feng GK, Zhou AJ, Cai MY, Zhong Q, Zeng MS, Huang XM.

Oncotarget. 2016 Mar 29;7(13):16910-22. doi: 10.18632/oncotarget.7626.

19.

EBV glycoproteins: where are we now?

Hutt-Fletcher LM.

Future Virol. 2015;10(10):1155-1162.

20.

Neuropilin-2 Regulates Endosome Maturation and EGFR Trafficking to Support Cancer Cell Pathobiology.

Dutta S, Roy S, Polavaram NS, Stanton MJ, Zhang H, Bhola T, Hönscheid P, Donohue TM Jr, Band H, Batra SK, Muders MH, Datta K.

Cancer Res. 2016 Jan 15;76(2):418-28. doi: 10.1158/0008-5472.CAN-15-1488. Epub 2015 Nov 11.

Supplemental Content

Support Center